Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jun 15 2021

Full Issue

Delta Variant Twice As Likely To Cause Hospitalization, Study Shows

Researchers in Scotland compared delta to the alpha strain, formerly referred to as the U.K. variant.

Fox News: Delta COVID-19 Variant Doubles Risk Of Hospitalization Compared To Alpha Strain, Scottish Study Finds

A study out of Scotland has found the Delta COVID-19 variant carries double the risk of hospitalization compared to the Alpha strain, particularly in patients with five or more comorbidities. Scotland had determined that the Delta variant became the dominant strain in the country about a month ago. Using the country’s COVID-19 surveillance program, researchers on behalf of Public Health Scotland analyzed data to investigate risk of hospital admission and estimate vaccinate effectiveness at preventing hospital admissions among likely Delta variant cases. The study was published Monday in The Lancet. (Hein, 6/14)

Bloomberg: Delta Variant: Pfizer, AstraZeneca Vaccines Shown Effective Vs. Hospitalizations

Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc are highly effective after two doses at preventing hospitalization of those infected with the delta variant, underscoring the urgency in getting people fully protected, according to health authorities in England. The Pfizer and BioNTech SE shot is 96% effective against hospitalization after two doses, while the AstraZeneca and University of Oxford Covid inoculation is 92% effective, according to an analysis announced Monday by Public Health England. Those results are comparable with the protection offered against the alpha variant, which first emerged in Britain, the data show. (Gemmell and Paton, 6/14)

Fox News: Delta COVID-19 Variant 'Probably Going To Become' Dominant Strain In US, Gottlieb Says

The former head of the FDA said that while the Delta variant currently accounts for about 10% of coronavirus infections in the U.S., it’s doubling at a rate of every two weeks meaning "it’s probably going to become the dominant strain." However, Dr. Scott Gottlieb, who was appearing on CBS’s "Face the Nation," said, that doesn’t necessarily mean there will be a sharp rise in infections over the coming weeks. (Hein, 6/14)

AP: Vaccinated Hawaiian Positive For Delta Variant

Hawaii says a vaccinated Oahu resident who traveled to Nevada last month has tested positive for the delta variant of COVID-19. The delta variant was first detected in India and is a more transmissible version of the disease. The variant currently makes up 6% of all cases in the U.S. Hawaii Health Director Dr. Libby Char says this is a “very rare breakthrough” case in which a COVID-19 vaccine didn’t prevent infection. (6/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF